The Effects of the Pro12Ala Polymorphism of the Peroxisome Proliferator-Activated Receptor-γ2 Gene on Insulin Sensitivity and Insulin Metabolism Interact With Size at Birth
Open Access
- 1 July 2002
- journal article
- Published by American Diabetes Association in Diabetes
- Vol. 51 (7) , 2321-2324
- https://doi.org/10.2337/diabetes.51.7.2321
Abstract
Type 2 diabetes is known to be associated with a small body size at birth. Body size at birth is an indicator of the intrauterine environment. There is also a well-established association between the peroxisome proliferator-activated receptor (PPAR)-γ2 gene and type 2 diabetes. We therefore assessed whether the effects of the Pro12Ala polymorphism of the PPAR-γ2 gene on insulin sensitivity and insulin concentrations in adult life are modified by size at birth. We found that the effects of the Pro12Pro and Pro12Ala polymorphisms of the PPAR-γ2 gene in elderly people depended on their body size at birth. The well-known association between small body size at birth and insulin resistance was seen only in individuals with the high-risk Pro12Pro allele. In those who had low birth weight, the Pro12Pro polymorphism of the PPAR-γ2 gene was associated with increased insulin resistance (P < 0.002) and elevated insulin concentrations (P < 0.003). These interactions between the effects of the Pro12Ala polymorphisms of the PPAR-γ2 gene on adult traits and the effects of birth weight link two previously unknown associations together within the context of type 2 diabetes. We suggest that these findings reflect gene-environment interaction.Keywords
This publication has 27 references indexed in Scilit:
- Identification of a Novel Peroxisome Proliferator-Activated Receptor (PPAR) γ Promoter in Man and Transactivation by the Nuclear Receptor RORα1Biochemical and Biophysical Research Communications, 2001
- Association between the P12A and c1431t polymorphisms in the peroxisome proliferator activated receptor γ (PPARγ) gene and type 2 diabetesExperimental and Clinical Endocrinology & Diabetes, 2001
- TrueInternational Journal of Obesity, 2001
- Peroxisome Proliferator-Activated Receptor- 2 P12A and Type 2 Diabetes in Canadian Oji-CreeJournal of Clinical Endocrinology & Metabolism, 2000
- Impact of the Peroxisome Proliferator Activated Receptor γ2 Pro12Ala polymorphism on adiposity, lipids and non-insulin-dependent diabetes mellitusInternational Journal of Obesity, 2000
- Two Polymorphisms in the Peroxisome Proliferator-Activated Receptor- Gene Are Associated with Severe Overweight among Obese WomenJournal of Clinical Endocrinology & Metabolism, 1999
- The Wellcome Foundation Lecture, 1994. The fetal origins of adult diseaseProceedings Of The Royal Society B-Biological Sciences, 1995
- Fetal and infant growth and impaired glucose tolerance at age 64.BMJ, 1991
- WEIGHT IN INFANCY AND DEATH FROM ISCHAEMIC HEART DISEASEThe Lancet, 1989
- RAT FOETAL ENDOCRINE PANCREAS IN EXPERIMENTAL DIABETESJournal of Endocrinology, 1977